The Effectiveness of Thoracal Epidural Steroid and Local Anesthetic Injection
1 other identifier
interventional
100
1 country
1
Brief Summary
The primary objective was to evaluate the effectiveness of thoracic interlaminar epidural injections in alleviating pain and enhancing function in patients suffering from chronic mid and/or upper back pain. Materials and Methods One hundred patients were randomly divided into two groups, each consisting of 50 patients. Group I received only a local anesthetic, while Group II received a combination of local anesthetic and steroids. The random assignment to either Group I or Group II was determined using a simple computer-generated sequence. Outcomes were evaluated using the Numeric Rating Scale (NRS) and the revised Oswestry Disability Index (rODI). Patients who showed significant improvement for more than four weeks after the first two procedures were deemed successful. Those who did not were classified as failed participants. Significant improvement was defined as a reduction of more than 50% in both NRS and rODI scores, with assessments conducted at baseline and at 3, 6, and 12 months post-treatment. The center where the study was conducted: Ankara University, Faculty of Medicine, Department of Anesthesiology and Reanimation, Division of Algology, Ankara, Turkey
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedFirst Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 18, 2024
CompletedJuly 18, 2024
July 1, 2024
2.4 years
June 26, 2024
July 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The effect of thoracic epidural injection on upper back pain
Change in Visual Analog Score after the procedure. The visual analog scale (VAS) of pain intensity consists of a line, most often 100 mm long, with 2 descriptors representing extremes of pain intensity (eg, no pain and extreme pain)at each end. The findings suggested that 100-mm VASratings of 0 to 4 mmcanbeconsidered nopain; 5 to 44mm,mildpain; 45 to 74mm, moderate pain; and 75 to 100 mm, severe pain.
1 year
The effect of thoracic epidural steroid and local anesthetic injection on upper back pain
Change The Oswestry Disability Index (ODI) after the procedure: ODI is an index used by clinicians and researchers to quantify disability for low back pain and quality of life. The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible. 0% -20%: Minimal disability;21%-40%: Moderate Disability;41%-60%: Severe Disability;61%-80%: Crippling back pain;81%-100%;The patient is either bed-bound or has an exaggeration of their symptoms.
1 year
Secondary Outcomes (3)
The effect of thoracic epidural steroid and local anesthetic injection on upper back pain
1 year
The effect of thoracic epidural steroid and local anesthetic injection on upper back pain
1 year
The effect of thoracic epidural steroid and local anesthetic injection on upper back pain
1 year
Study Arms (2)
Local Group
OTHERGroup I received thoracic interlaminar epidural injections of 6 mL of 2% preservative-free prilocaine.
Local+steroid Group
OTHERGroup II received injections of 4 mL of 2% preservative-free prilocaine combined with 2 mL or 8 mg of dexamethasone, totaling 6 mL
Interventions
. Injections were administered under sedation and sterile conditions, with all patients positioned prone and monitored. A single physician performed all injections using an 18 gauge Tuohy needle, employing the loss of resistance technique and confirming the epidural space placement with 5 mL of nonionic contrast.
Eligibility Criteria
You may qualify if:
- \> 18 years old
- \> 6 months pain duration
- Failed conservative management (including medication, physical therapy, and exercise programs)
- Facet joint pain ruled out (confirmed through diagnostic blocks)
You may not qualify if:
- \< 18 years old
- Having a psychological illness
- Allergies to local anesthetics or steroids
- Thoracic facet joint pain
- Significant disc herniation
- Infection ( which were ruled out by pre-procedure blood tests and C-reactive protein levels)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 18, 2024
Study Start
August 15, 2021
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
July 18, 2024
Record last verified: 2024-07